José Refugio Torres-Nava
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by José Refugio Torres-Nava.
BMC Cancer | 2011
María Luisa Pérez-Saldivar; Arturo Fajardo-Gutiérrez; Roberto Bernáldez-Ríos; Armando Martínez-Avalos; Aurora Medina-Sanson; Laura Espinosa-Hernández; José de Diego Flores-Chapa; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Francisco Javier Álvarez-Rodríguez; Victoria Bolea-Murga; Janet Flores-Lujano; María del Carmen Rodríguez-Zepeda; Roberto Rivera-Luna; Elisa Dorantes-Acosta; Elva Jiménez-Hernández; Martha Alvarado-Ibarra; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; David Aldebarán Duarte-Rodríguez; Rogelio Paredes-Aguilera; Maria de los Angeles del Campo-Martinez; Rocio Cardenas-Cardos; Paola Hillary Alamilla-Galicia; Vilma Carolina Bekker-Méndez; Manuel Carlos Ortega-Alvarez; Juan Manuel Mejía-Aranguré
BackgroundWorldwide, acute leukemia is the most common type of childhood cancer. It is particularly common in the Hispanic populations residing in the United States, Costa Rica, and Mexico City. The objective of this study was to determine the incidence of acute leukemia in children who were diagnosed and treated in public hospitals in Mexico City.MethodsIncluded in this study were those children, under 15 years of age and residents of Mexico City, who were diagnosed in 2006 and 2007 with leukemia, as determined by using the International Classification of Childhood Cancer. The average annual incidence rates (AAIR), and the standardized average annual incidence rates (SAAIR) per million children were calculated. We calculated crude, age- and sex-specific incidence rates and adjusted for age by the direct method with the world population as standard. We determined if there were a correlation between the incidence of acute leukemias in the various boroughs of Mexico City and either the number of agricultural hectares, the average number of persons per household, or the municipal human development index for Mexico (used as a reference of socio-economic level).ResultsAlthough a total of 610 new cases of leukemia were registered during 2006-2007, only 228 fit the criteria for inclusion in this study. The overall SAAIR was 57.6 per million children (95% CI, 46.9-68.3); acute lymphoblastic leukemia (ALL) was the most frequent type of leukemia, constituting 85.1% of the cases (SAAIR: 49.5 per million), followed by acute myeloblastic leukemia at 12.3% (SAAIR: 6.9 per million), and chronic myeloid leukemia at 1.7% (SAAIR: 0.9 per million). The 1-4 years age group had the highest SAAIR for ALL (77.7 per million). For cases of ALL, 73.2% had precursor B-cell immunophenotype (SAAIR: 35.8 per million) and 12.4% had T-cell immunophenotype (SAAIR 6.3 per million). The peak ages for ALL were 2-6 years and 8-10 years. More than half the children (58.8%) were classified as high risk. There was a positive correlation between the average number of persons per household and the incidence of the pre-B immunophenotype (Pearsons r, 0.789; P = 0.02).ConclusionsThe frequency of ALL in Mexico City is among the highest in the world, similar to those found for Hispanics in the United States and in Costa Rica.
BioMed Research International | 2014
Vilma Carolina Bekker-Méndez; Enrique Miranda-Peralta; Juan Carlos Núñez-Enríquez; Irma Olarte-Carrillo; Francisco Xavier Guerra-Castillo; Ericka N. Pompa-Mera; Alicia Ocaña-Mondragón; Angélica Rangel-López; Roberto Bernáldez-Ríos; Aurora Medina-Sanson; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; José de Diego Flores-Chapa; Arturo Fajardo-Gutiérrez; Janet Flores-Lujano; María del Carmen Rodríguez-Zepeda; Elisa Dorantes-Acosta; Victoria Bolea-Murga; Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; César González-Bonilla; Juan Manuel Mejía-Aranguré
Mexico has one of the highest incidences of childhood leukemia worldwide and significantly higher mortality rates for this disease compared with other countries. One possible cause is the high prevalence of gene rearrangements associated with the etiology or with a poor prognosis of childhood acute lymphoblastic leukemia (ALL). The aims of this multicenter study were to determine the prevalence of the four most common gene rearrangements [ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, and MLL rearrangements] and to explore their relationship with mortality rates during the first year of treatment in ALL children from Mexico City. Patients were recruited from eight public hospitals during 2010–2012. A total of 282 bone marrow samples were obtained at each childs diagnosis for screening by conventional and multiplex reverse transcription polymerase chain reaction to determine the gene rearrangements. Gene rearrangements were detected in 50 (17.7%) patients. ETV6-RUNX1 was detected in 21 (7.4%) patients, TCF3-PBX1 in 20 (7.1%) patients, BCR-ABL1 in 5 (1.8%) patients, and MLL rearrangements in 4 (1.4%) patients. The earliest deaths occurred at months 1, 2, and 3 after diagnosis in patients with MLL, ETV6-RUNX1, and BCR-ABL1 gene rearrangements, respectively. Gene rearrangements could be related to the aggressiveness of leukemia observed in Mexican children.
British Journal of Cancer | 2013
Juan Carlos Núñez-Enríquez; Arturo Fajardo-Gutiérrez; E P Buchán-Durán; Roberto Bernáldez-Ríos; Aurora Medina-Sanson; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Rogelio Paredes-Aguilera; Francisco Javier Álvarez-Rodríguez; Victoria Bolea-Murga; J. de Diego Flores-Chapa; Janet Flores-Lujano; Vilma Carolina Bekker-Méndez; Roberto Rivera-Luna; M del Carmen Rodriguez-Zepeda; Angélica Rangel-López; Elisa Dorantes-Acosta; Nora Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; Rocio Cardenas-Cardos; Luz Victoria Flores-Villegas; Armando Martínez-Avalos; Fabio Salamanca-Gómez; C Gorodezky; José Arellano-Galindo; Juan Manuel Mejía-Aranguré
Background:Allergies have been described as protective factors against the development of childhood acute leukaemia (AL). Our objective was to investigate the associations between allergy history and the development of AL and acute lymphoblastic leukaemia (ALL) in children with Down syndrome (DS).Methods:A case–control study was performed in Mexico City. The cases (n=97) were diagnosed at nine public hospitals, and the controls (n=222) were recruited at institutions for children with DS. Odds ratios (OR) were calculated.Results:Asthma was positively associated with AL development (OR=4.18; 95% confidence interval (CI): 1.47–11.87), whereas skin allergies were negatively associated (OR=0.42; 95% CI: 0.20–0.91).Conclusion:Our findings suggest that allergies and AL in children with DS share biological and immune mechanisms. To our knowledge, this is the first study reporting associations between allergies and AL in children with DS.
Leukemia & Lymphoma | 2017
Jorge Alfonso Martín-Trejo; Juan Carlos Núñez-Enríquez; Arturo Fajardo-Gutiérrez; Aurora Medina-Sanson; Janet Flores-Lujano; Elva Jiménez-Hernández; Raquel Amador-Sánchez; José Gabriel Peñaloza-González; Francisco Javier Álvarez-Rodríguez; Victoria Bolea-Murga; Rosa Martha Espinosa-Elizondo; José de Diego Flores-Chapa; María Luisa Pérez-Saldivar; María del Carmen Rodríguez-Zepeda; Elisa Dorantes-Acosta; Nora Nancy Núñez-Villegas; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Nancy Reyes-Zepeda; César González-Bonilla; Luz Victoria Flores-Villegas; Angélica Rangel-López; Roberto Rivera-Luna; Rogelio Paredes-Aguilera; Rocio Cardenas-Cardos; Armando Martínez-Avalos; Ana Elena Gil-Hernández; David Aldebarán Duarte-Rodríguez; Juan Manuel Mejía-Aranguré
Abstract The role of malnutrition at diagnosis as a predictor of early mortality in Mexican leukemia children remains controversial. The objective of present study was to investigate whether malnutrition was a predictor of early mortality during the first year of treatment in Mexican acute lymphoblastic leukemia (ALL) children through the first population-based study. A total of 794 newly diagnosed ALL pediatric patients from public hospitals of Mexico City were enrolled. A multivariate Cox proportional hazards regression model was constructed and adjusted by patient’s age at diagnosis, gender, hospital of treatment, and socioeconomic status. Early mortality was high (12.1%) and malnutrition by different indicators was not associated with mortality at induction phase and at 6th month; a high risk of dying (RR = 2.08; 95% CI: 1.08–4.01) was observed in the group of malnourished children with a high-risk ALL.
International Journal of Oncology | 2016
María Sánchez-Cuaxospa; Alejandra Contreras-Ramos; Erandi Pérez-Figueroa; Aurora Medina-Sansón; Elva Jiménez-Hernández; José Refugio Torres-Nava; Emilio Rojas-Castillo; Carmen Maldonado-Bernal
Cancer is the second most common cause of death among children aged 1-14 years. Leukemia accounts for one-third of all childhood cancers, 78% of which is acute lymphoblastic leukemia (ALL). The development of cancer has been associated with malignant cells that express low levels of immunogenic molecules, which facilitates their escape from the antineoplastic immune response. It is thought that it may be possible to rescue the antineoplastic immune response through the activation of recognition receptors, such as Toll-like receptors (TLRs), which activate the innate immune system. TLRs are type I membrane glycoproteins expressed mainly in immune system cells such as monocytes, neutrophils, macrophages, dendritic cells, T, B and natural killer cells. The aim of the present study was to evaluate the expression of TLR1, TLR3, TLR4, TLR7 and TLR9 in peripheral blood mononuclear cells (PBMCs) in patients with ALL and prior to any treatment. PBMCs were obtained from 50 pediatric patients diagnosed with ALL and from 20 children attending the ophthalmology and orthopedics services. The mean fluorescence intensity was obtained by analysis of immunofluorescence. We found lower expression levels of TLR1, TLR3, TLR4, TLR7 and TLR9 in PBMCs from patients with ALL compared with those from control patients. We also observed that the PBMCs from patients with Pre-B and B ALL had lower TLR4 expression than controls and patients with Pro-B, Pre-B, B and T ALL had lower TLR7 expression than controls. The present study is the first to demonstrate reduced expression of TLRs in PBMCs from pediatric patients with ALL. This finding is of great relevance and may partly explain the reduction in the antineoplastic immune response in patients with ALL.
BioMed Research International | 2014
Abigail Morales-Sánchez; Ericka N. Pompa-Mera; Arturo Fajardo-Gutiérrez; Francisco Javier Álvarez-Rodríguez; Vilma Carolina Bekker-Méndez; J. de Diego Flores-Chapa; Janet Flores-Lujano; Elva Jiménez-Hernández; José Gabriel Peñaloza-González; María del Carmen Rodríguez-Zepeda; José Refugio Torres-Nava; Martha Margarita Velázquez-Aviña; Raquel Amador-Sánchez; Martha Alvarado-Ibarra; Nancy Reyes-Zepeda; Rosa Martha Espinosa-Elizondo; María Luisa Pérez-Saldivar; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Ezequiel M. Fuentes-Pananá
Acute lymphoblastic leukemia (ALL) is the most common cancer in childhood worldwide and Mexico has reported one of the highest incidence rates. An infectious etiology has been suggested and supported by epidemiological evidences; however, the identity of the involved agent(s) is not known. We considered that early transmitted lymphotropic herpes viruses were good candidates, since transforming mechanisms have been described for them and some are already associated with human cancers. In this study we interrogated the direct role of EBV, HCMV, HHV6, and HHV7 human herpes viruses in childhood ALL. Viral genomes were screened in 70 bone marrow samples from ALL patients through standard and a more sensitive nested PCR. Positive samples were detected only by nested PCR indicating a low level of infection. Our result argues that viral genomes were not present in all leukemic cells, and, hence, infection most likely was not part of the initial genetic lesions leading to ALL. The high statistical power of the study suggested that these agents are not involved in the genesis of ALL in Mexican children. Additional analysis showed that detected infections or coinfections were not associated with prognosis.
Oncology Reports | 2016
E. Pérez-Figueroa; M. Sánchez-Cuaxospa; K. A. Martínez-Soto; N. Sánchez-Zauco; Aurora Medina-Sansón; E. Jiménez-Hernández; José Refugio Torres-Nava; J. M. Félix-Castro; A. Gómez; E. Ortega; Carmen Maldonado-Bernal
Children with acute lymphoblastic leukemia (ALL) often present fever. Febrile states are usually associated with infectious processes that generate an inflammatory response involving various molecules, including cytokines. However, an inflammatory response may also occur in the absence of infection. We hypothesized that the levels of inflammatory cytokines are increased in children with ALL without apparent infection. The serum levels of 13 cytokines in 99 patients with ALL and 48 non-oncological patients without apparent infection were measured using multiplex analyte profiling technology (Luminex®). The concentration of circulating pro-inflammatory cytokines associated with fever was similar between patients with ALL and fever at diagnosis and those without fever. The levels of tumor necrosis factor α, interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and IL-10 were higher in patients with ALL vs. the control group (P<0.05). Moreover, the levels of the T helper 1 (interferon‑γ and IL-12) cytokines were higher in patients with ALL vs. the control group. Transforming growth factor β was lower in patients with ALL vs. the control group (P<0.05). The levels of IL-1β, IL-2, IL-4, IL-13, and IL-17 were similar in the two groups. Our results indicate that the circulating levels of seven of the important studied cytokines are elevated in patients with newly diagnosed ALL without apparent infection, reflecting a strong and deregulated inflammatory state in this disease, with a Th1-polarization profile.
Cancer Epidemiology, Biomarkers & Prevention | 2013
Abigail Morales-Sánchez; Roberto Bernáldez-Ríos; Francisco Javier Álvarez-Rodríguez; Vilma Carolina Bekker-Méndez; Arturo Fajardo-Gutiérrez; José de Diego Flores-Chapa; Janet Flores-Lujano; Elva Jiménez-Hernández; José Gabriel Peñaloza-González; María del Carmen Rodríguez-Zepeda; José Refugio Torres-Nava; Martha Margarita Velázquez-Aviña; Raquel Amador-Sánchez; Martha Alvarado-Ibarra; Nancy Reyes-Zepeda; Rosa Martha Espinosa-Elizondo; Ezequiel M. Fuentes-Pananá; Juan Manuel Mejía-Aranguré
Background: In Mexico City, the incidence of childhood acute lymphoblastic leukemia (ALL) is one of the highest in the world; epidemiologic evidence suggests that infectious agents could be involved in the genesis of this disease. Early transmitted oncogenic retroviruses infecting lymphocytes are important candidates. Methods: PCR-based assays were used to screen viral genomic sequences of human T-cell lymphotrophic virus, type 1 (HTLV1) and mouse mammary tumor virus (MMTV)–like virus (MMTV-LV) in leukemic cells from 67 pediatric patients with ALL. Results: Viral genomic sequences were not detected in any sample by neither standard nor nested PCR. Conclusions: Because of the methodologic strictness and high statistical power of the study, these results suggest that HTLV1 and MMTV-LV are not involved in the genesis of childhood ALL in Mexican children. Impact: To our knowledge, this is the first work exploring the direct participation of HTLV1 and MMTV-LV retroviruses in childhood ALL development. Cancer Epidemiol Biomarkers Prev; 22(11); 2130–3. ©2013 AACR.
Archives of Medical Research | 2016
Beatriz Rosales-Rodríguez; Fernando Fernández-Ramírez; Juan Carlos Núñez-Enríquez; Ana Claudia Velázquez-Wong; Aurora Medina-Sanson; Elva Jiménez-Hernández; Janet Flores-Lujano; José Gabriel Peñaloza-González; Rosa Martha Espinosa-Elizondo; María Luisa Pérez-Saldivar; José Refugio Torres-Nava; Jorge Alfonso Martín-Trejo; Gabriela Bibiana Martínez-Morales; Vilma Carolina Bekker-Méndez; Juan Manuel Mejía-Aranguré; Haydeé Rosas-Vargas
B-cell precursor acute lymphocytic leukemia (B-ALL) represents a worldwide public health issue. Particularly, Mexico is one of the countries with the highest incidence of ALL in children. Between the multiple factors involved in ALL etiology, genetic alterations are clearly one of the most relevant features. In this work, a group of 24 B-ALL patients, all negative for the four most frequent gene fusions (ETV6-RUNX1, BCR-ABL1, TCF3-PBX1 and MLL-AF4), were included in a high-resolution microarray analysis in order to evaluate genomic copy-number alterations (CNAs). The results of this preliminary report showed a broad genomic heterogeneity among the studied samples; 58% of the patients were hyperdiploid and 33% displayed a chromosome 9p deletion of variable length affecting genes CDKN2A/B, two patients displayed genomic instability with a high number of focal CNAs, three patients presented unique duplications affecting 2q, 12p and 1q, respectively, and one patient displayed no copy number imbalances. The copy-number profile of 44 genes previously related to B-ALL was heterogeneous as well. Overall results highlight the need for a detailed description of the genetic alterations in ALL cancer cells in order to understand the molecular pathogenesis of the disease and to identify any prognostic markers with clinical significance.
Gaceta Medica De Mexico | 2016
Juan Manuel Mejía-Aranguré; Juan Carlos Núñez-Enríquez; Arturo Fajardo-Gutiérrez; María del Carmen Rodríguez-Zepeda; Jorge Alfonso Martín-Trejo; David Aldebarán Duarte-Rodríguez; Aurora Medina-Sanson; Janet Flores-Lujano; Elva Jiménez-Hernández; Nora Nancy Núñez-Villegas; María Luisa Pérez-Saldivar; Rogelio Paredes-Aguilera; Rocio Cardenas-Cardos; José de Diego Flores-Chapa; Nancy Reyes-Zepeda; Luz Victoria Flores-Villegas; Raquel Amador-Sánchez; José Refugio Torres-Nava; Victoria Bolea-Murga; Rosa Martha Espinosa-Elizondo; José Gabriel Peñaloza-González; Martha Margarita Velázquez-Aviña; César ar González-Bonilla; Vilma Carolina Bekker-Méndez; Silvia Jiménez-Morales; Gabriela Bibiana Martínez-Morales; Haydeé Rosas Vargas; Angélica Rangel-López